This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
Ira Shafran, MD
Advertisement
Articles by Ira Shafran, MD
Advertisement
Latest Updated Articles
- Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD
Published: April 20th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Gluteus Maximus Muscle Shape Changes Tied to Aging, Frailty, and Type 2 Diabetes
2
FDA Approves Reformulated Ranitidine After 5-Year Absence
3
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
4
Zuranolone Offers New Hope for Postpartum Depression
5
